Edwards receives approval for SAPIEN 3 heart valve in Canada
Edwards Lifesciences announced that Health Canada has approved the Edwards SAPIEN 3 transcatheter heart valve for the treatment of patients living with severe, symptomatic aortic stenosis and at high or greater risk for surgical aortic valve replacement. July 27, 2016